Javelin’s multidimensional approach introduces a new capability to precision immune medicine. This enables us to predict patient responses to treatment, significantly reducing the time and resources required to launch new immunotherapies.
We apply our platform both to create novel therapies in our own labs and as a service to other life sciences companies to help them advance their discovery and development of immuno-oncology therapies. Our goal is to utilize our capabilities to transform outcomes for as many patients as possible by creating effective and safe curative therapies. By making our technology available to others, we can amplify our impact.